109 related articles for article (PubMed ID: 7913248)
21. Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis.
Bellone G; Trinchieri G
J Immunol; 1994 Aug; 153(3):930-7. PubMed ID: 7517976
[TBL] [Abstract][Full Text] [Related]
22. Interleukins 2 and 12 produce recovery of cytotoxic function in tributyltin-exposed human natural killer cells.
Whalen MM; Williams TB; Green SA; Loganathan BG
Environ Res; 2002 Mar; 88(3):199-209. PubMed ID: 12051798
[TBL] [Abstract][Full Text] [Related]
23. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
24. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
[TBL] [Abstract][Full Text] [Related]
25. Differences in natural killer cell quantification and receptor profile expression in HIV-1 infected Chinese children.
Fu GF; Chen X; Hao S; Zhao JL; Hu HY; Yang HT; Xu XQ; Qiu T; Li L; Xu JS; Liu XY; Huan XP; Hou YY
Cell Immunol; 2010; 265(1):37-43. PubMed ID: 20678758
[TBL] [Abstract][Full Text] [Related]
26. A pilot study of intralymphatic interleukin-2. I. Cytotoxic and surface marker changes of peripheral blood lymphocytes.
Shau H; Isacescu V; Ibayashi Y; Tokuda Y; Golub SH; Fahey JL; Sarna GP
J Biol Response Mod; 1990 Feb; 9(1):71-80. PubMed ID: 2319261
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies.
Soiffer RJ; Robertson MJ; Murray C; Cochran K; Ritz J
Blood; 1993 Nov; 82(9):2790-6. PubMed ID: 8106018
[TBL] [Abstract][Full Text] [Related]
28. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients.
Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL
Thymus; 1997; 24(3):147-56. PubMed ID: 9151380
[TBL] [Abstract][Full Text] [Related]
29. Lytic activity of IL-2 and IL-12 stimulated NK cells against HOS osteosarcoma cell line.
Mariani E; Tarozzi A; Meneghetti A; Tadolini M; Facchini A
Boll Soc Ital Biol Sper; 1996; 72(1-2):21-7. PubMed ID: 8868111
[TBL] [Abstract][Full Text] [Related]
30. Defective natural immunity: an early manifestation of human immunodeficiency virus infection.
Ullum H; Gøtzsche PC; Victor J; Dickmeiss E; Skinhøj P; Pedersen BK
J Exp Med; 1995 Sep; 182(3):789-99. PubMed ID: 7650485
[TBL] [Abstract][Full Text] [Related]
31. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation.
Trinchieri G; Wysocka M; D'Andrea A; Rengaraju M; Aste-Amezaga M; Kubin M; Valiante NM; Chehimi J
Prog Growth Factor Res; 1992; 4(4):355-68. PubMed ID: 1364096
[TBL] [Abstract][Full Text] [Related]
32. Augumentation of natural killer activity with exogenous interleukins in patients with HIV and pulmonary tuberculosis coinfection.
Ramana Rao PV; Rajasekaran S; Raja A
AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1435-43. PubMed ID: 19000024
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic activity against HIV-infected monocytes by recombinant interleukin 2-activated natural killer cells.
Melder RJ; Balachandran R; Rinaldo CR; Gupta P; Whiteside TL; Herberman RB
AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1011-5. PubMed ID: 2223237
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT
Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875
[TBL] [Abstract][Full Text] [Related]
35. Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis.
Tasca S; Tambussi G; Nozza S; Capiluppi B; Zocchi MR; Soldini L; Veglia F; Poli G; Lazzarin A; Fortis C
AIDS; 2003 Nov; 17(16):2291-8. PubMed ID: 14571180
[TBL] [Abstract][Full Text] [Related]
36. Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-gamma production of porcine natural killer cells.
Pintaric M; Gerner W; Saalmüller A
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):68-82. PubMed ID: 17913242
[TBL] [Abstract][Full Text] [Related]
37. IL-21 enhances NK cell functions and survival in healthy and HIV-infected patients with minimal stimulation of viral replication.
Iannello A; Boulassel MR; Samarani S; Tremblay C; Toma E; Routy JP; Ahmad A
J Leukoc Biol; 2010 May; 87(5):857-67. PubMed ID: 20103765
[TBL] [Abstract][Full Text] [Related]
38. Interleukins 2 and 12 produce significant recovery of cytotoxic function in dibutyltin-exposed human natural killer cells.
Whalen MM; Walker L; Loganathan BG
Environ Res; 2002 Feb; 88(2):103-15. PubMed ID: 11908935
[TBL] [Abstract][Full Text] [Related]
39. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.
Clerici M; Lucey DR; Berzofsky JA; Pinto LA; Wynn TA; Blatt SP; Dolan MJ; Hendrix CW; Wolf SF; Shearer GM
Science; 1993 Dec; 262(5140):1721-4. PubMed ID: 7903123
[TBL] [Abstract][Full Text] [Related]
40. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation.
Nagler A; Lanier LL; Phillips JH
J Immunol; 1988 Oct; 141(7):2349-51. PubMed ID: 3262658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
